Allergy Therapeutics plc Preliminary Results for the year ended 30 June 2020
23 sept. 2020 07h00 HE
|
Allergy Therapeutics
Allergy Therapeutics plc (“Allergy Therapeutics”, “ATL” or the “Group”) Preliminary Results for the year ended 30 June 2020 Record level of pre R&D operating profit supported by robust sales...
Ergomed plc Interim results for the six months ended 30 June 2020
22 sept. 2020 07h00 HE
|
Ergomed plc
PRESS RELEASE Interim results for the six months ended 30 June 2020 Services strategy drives revenue and profit growthOrder book growth underpins high forward visibility Total revenue growth of...
Seluxit Half-year financial report – H1 2019/20
06 févr. 2020 04h30 HE
|
Seluxit A/S
Seluxit Half-year financial report – H1 2019/20 Company Announcement No. 18 Aalborg, February 6th, 2020 Seluxit presents a half-year report, which shows a satisfactory result and maintains the...
Halvårsrapport Seluxit – Første halvår 2019/20
06 févr. 2020 04h30 HE
|
Seluxit A/S
Halvårsrapport Seluxit – Første halvår 2019/20 Selskabsmeddelelse nr. 18 Aalborg, 6. februar 2020 Seluxit præsenterer en halvårsrapport med tilfredsstillende resultater og fastholder...
Half year financial report Seluxit – first half year 2018/2019 - Announcement nr. 6 2018/2019
21 févr. 2019 07h39 HE
|
Seluxit A/S
MUST NOT BE PUBLISHED, DISTRIBUTED OR SHARED, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. Half year financial report Seluxit – first half year 2018/2019 Company...
Halvårsrapport Seluxit – første halvår 2018/2019 - Meddelelse nr. 6 2018/2019
21 févr. 2019 07h39 HE
|
Seluxit A/S
MÅ IKKE OFFENTLIGGØRES, DISTRIBUERES ELLER UDLEVERES HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I ELLER TIL USA, AUSTRALIEN, CANADA ELLER JAPAN Halvårsrapport Seluxit – første halvår 2018/2019 ...